Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.550
+0.030 (1.19%)
Oct 19, 2026, 4:10 PM AEST
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 208.82 million as of October 19, 2026. It is the 22,679th most valuable company in the world and the 458th biggest in Australia. Its market cap has decreased by 58.48% in one year.
Market Cap
208.82M
Enterprise Value
172.02M
Revenue
383.68M
Global Rank
Country Rank
#458 Australia
PE Ratio
9.41
ChartMarket Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 208.82M, an increase of 357.35%. That is a compound annual growth rate of 8.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 208.82M | -17.36% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 92.93B |
| Sigma Healthcare | 32.55B |
| Pro Medicus | 18.56B |
| Ramsay Health Care | 12.66B |
| Monash IVF Group | 278.59M |
| Healius | 275.94M |
| Paragon Care | 248.30M |
| BLS Pharmaceuticals | 238.37M |